ABSTRACTS

P2.09 Impact of minimal residual disease monitoring on therapy in Belgian childhood acute lymphoblastic leukaemia

BJH - volume 5, issue Abstract Book BHS, january 2014

J. Van Der Straeten MSc, B. De Moerloose MD, PhD, M-F. Dresse MD, PhD, S. Dupont MD, A. Ferster MD, PhD, P. Philippet MD, A. Uyttebroeck MD, PhD, J. Van der Werf ten Bosch , C. Demanet MD, PhD, Y Benoit MD, PhD, M. Bakkus PhD

Read more

P2.10 BRAF V600E mutation is not a disease-defining genetic event in classic hairy cell leukemia

BJH - volume 5, issue Abstract Book BHS, january 2014

F. Nollet PhD, MSc, K. Boon , J. Emmerechts MD, PhD, S. Vermeire , R. D’Hondt , A. Van Hoof MD, PhD, D. Selleslag MD, J. Van Droogenbroeck MD, T. Lodewyck MD, J. Billiet MD

Read more

P2.11 Activating JAK1 and JAK3 mutations cooperate to confer growth signal self-sufficiency and increased resistance to JAK inhibitors in a mouse in vitro leukemia model

BJH - volume 5, issue Abstract Book BHS, january 2014

L. Springuel , E. Losdyck , T. Hornakova , L. Knoops MD, PhD, J.C. Renauld

Read more

P2.12 An unusual presentation of cryptococcal meningitis in a patient with lymphoplasmacytic dyscrasia

BJH - volume 5, issue Abstract Book BHS, january 2014

F. Van Obbergh MD, A. Ferrant , D. Wilmes , J. Yombi , L. Knoops MD, PhD, M.C. Vekemans MD, L. Michaux MD, PhD

Read more

P2.13 Management of refractory/relapsed diffuse large B-cell lymphoma (DLBCL): the gap between guidelines and real world

BJH - volume 5, issue Abstract Book BHS, january 2014

M. Salati , M. Cesaretti , S. Luminari , M. Federico

Read more